Objective: To investigate the clinical and histopathological features of cervical basal squamous cell carcinoma (BSCC). Methods: A retrospective analysis of 10 cases of cervical BSCC was carried out. The clinical data and all the pathological sections were reviewed, the related immunohistochemical results were statistically analyzed, the clinicopathological features were analyzed, and then followed the prognosis. Results: (1) Clinical features: the median onset age of BSCC in cervix was 51 years old (ranged 35-69 years old), 5 of them were postmenopausal women. Vaginal bleeding was often seen in clinic (7 cases). Of the 10 cervical BSCC patients, 5 tested HPV types. All of them were HPV positive, including 2 cases of HPV 16 positive and 1 case of high-risk HPV positive. At the time of colposcopy, 3 cases showed exogenous nodular mass, 3 cases showed endogenous infiltrating mass, and 4 cases had unclear type of mass.(2)Treatment: of the 10 patients, 8 underwent hysterectomy+bilateral adnexal excision+pelvic lymphadenectomy, of which 6 underwent radiotherapy or chemotherapy after operation.Radiotherapy and chemotherapy were performed only in 2 cases. (3) Pathological features: histologically, the tumor cells were nests and stripe like growth, which were composed of basal like tumor cells. The cells had obvious heteromorphosis, less cytoplasm, deep dyed nuclei and common nuclear mitosis, and there were often palisade like structures around the cell nests, and some cells in the center of the cell nests were found to have acne like necrosis. It could be mixed with normal squamous cell carcinoma and squamous epithelial lesion. Among the 10 patients, 6 had immunohistochemical results. BSCC mainly expressed p16 and squamous cell markers such as p63, cytokeratin (CK) 5/6 and p40 protein, the positive expression rates were 3/3, 3/3, 2/2 and 3/3, respectively. A few expressed CK7 protein, and the positive expression rate was 1/3. (4) Prognosis: follow-up time ranged from 1 week to 64 months, and 2 cases were lost to follow-up. Among the 8 follow-up patients, 3 had iliac bone, lung or skin metastasis, and 5 had no recurrence or metastasis during the follow-up period. Conclusions: BSCC of cervix is a rare malignant tumor of cervix associated with high-risk HPV infection, p16 is more positive. The treatment is similar to that of normal cervical squamous cell carcinoma. Surgical resection and radiotherapy and chemotherapy are the most effective methods according to the clinical stage. At present, the disease is considered to be highly aggressive and the poor prognosis.
目的: 探讨子宫颈基底样鳞癌(BSCC)的临床和病理特点。 方法: 对2013年3月—2018年7月解放军总医院病理科诊断的10例子宫颈BSCC患者的临床病理资料进行回顾性分析。 结果: (1)临床特点:子宫颈BSCC患者的发病年龄为35~69岁,中位年龄51岁,其中5例为绝经后妇女;临床表现多为阴道异常流血(7例)。10例子宫颈BSCC患者中,5例有HPV检查结果者均为HPV阳性,其中3例为高危型HPV阳性(包括2例HPV 16型阳性);10例患者均行阴道镜检查,其中3例为外生结节状肿物,3例为内生浸润型肿物,4例会诊患者的肿物类型不详;临床分期:5例为Ⅰb1期,1例为Ⅱa期,4例会诊患者的临床分期不详。(2)治疗:10例患者中,8例行子宫全切除+双侧附件(或输卵管)切除+盆腔淋巴清扫术,其中6例术后辅以放疗或化疗;2例仅行放、化疗。(3)病理特点:镜下观,子宫颈BSCC由胞质稀少、核深染的基底样细胞构成,肿瘤呈实性巢团状或岛状,细胞异型性明显,核分裂象多见,细胞巢周围的肿瘤细胞呈栅栏状排列,部分细胞巢的中央可见粉刺样坏死。子宫颈BSCC与普通型鳞癌、鳞状上皮内病变混合存在。10例患者中,6例有免疫组化法检测结果,主要表达p16及鳞癌的标志物如p63、细胞角蛋白(CK)5/6、p40蛋白,其阳性表达率分别为3/3、3/3、2/2、3/3;少数表达CK7蛋白,其阳性表达率为1/3。(4)预后:随诊时间为1周~64个月,失访2例;8例随访患者中,3例出现髂骨、肺或皮肤的转移,5例随访期内无复发、转移。 结论: 子宫颈BSCC是少见的子宫颈恶性肿瘤,与高危型HPV感染有关,p16蛋白呈阳性表达;治疗与子宫颈鳞癌相似,根据临床分期行手术治疗联合放、化疗的综合治疗。目前认为该病变具有较强的侵袭性,患者预后欠佳。.
Keywords: Carcinoma, squamous cell; Human papillomavirus 16; Papillomavirus infections; Uterine cervical neoplasms.